<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33297642</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0254-6450</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</Title><ISOAbbreviation>Zhonghua Liu Xing Bing Xue Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Epidemiological characteristics of severe cases of hand, foot, and mouth disease in China, 2008-2018].</ArticleTitle><Pagination><StartPage>1802</StartPage><EndPage>1807</EndPage><MedlinePgn>1802-1807</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112338-20200201-00063</ELocationID><Abstract><AbstractText><b>Objective:</b> To characterize the epidemiology of severe hand, foot and mouth disease (HFMD) in China from 2008 to 2018 and provide evidence for the prevention and control of severe HFMD. <b>Methods:</b> The incidence data of severe HFMD cases from 2008 to 2018 were collected from the National Notifiable Infectious Diseases Reporting System of Chinese Center for Disease Control and Prevention. Descriptive epidemiological methods were used to analyze distributions, pathogen constituent and change of severe HFMD. Joinpoint regression model was used to analyze the trends of severity rate, proportion of severe cases and severe fatality rate. <b>Results:</b> From 2008 to 2018, a total of 157 065 cases of severe HFMD were reported in China, with an average annual case-severity rate of 1.05/100 000, a severe case proportion of 0.76<i>%</i> and a severity-fatality rate of 2.34<i>%</i>. The severity rate and the proportion of severe cases showed a downward trend after 2010, and severe fatality rate decreased significantly after 2014. The severe cases mainly occurred in infants aged &#x2264;3 years (91.47<i>%</i>), more boys were affected than girls (1.78&#x2236;1). The median age of severe HFMD cases caused by EV-A71 was highest (1.99 years) and increased year by year, other enterovirus infection cases accounted for a higher proportion in infants aged &#x2264;1 year (66.56<i>%</i>). The incidence peak occurred during April-July, other enteroviruses replaced EV-A71 as the predominant serotype in 2018 (61.97<i>%</i>). The incidence of severe HFMD were high in some provinces in southwestern, central and eastern China. <b>Conclusion:</b> The overall severity rate, proportion of severe cases and severe fatality rate of HFMD in the mainland of China have shown a downward trend. The predominant pathogen in some provinces has changed from EV-A71 to other enteroviruses. It is necessary to strengthen the prevention and control of HFMD in key population, high incidence seasons and areas and carry out the surveillance of various pathogens of HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>J Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>T R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Miyun District Center for Disease Control and Prevention, Beijing 101500, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>F F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Y W</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Information Center, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Z R</ForeName><Initials>ZR</Initials><AffiliationInfo><Affiliation>Key Laboratory of Surveillance and Early-warning on Infectious Disease, Division of Infectious Disease Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016ZX 09101120-004</GrantID><Agency>Phase &#x2163; Clinical Application of Inactivated Enterovirus 71 Vaccine</Agency><Country/></Grant><Grant><GrantID>2018ZX10713001</GrantID><Agency>National Science and Technology Major Project of China</Agency><Country/></Grant><Grant><GrantID>L192014</GrantID><Agency>Beijing Natural Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Liu Xing Bing Xue Za Zhi</MedlineTA><NlmUniqueID>8208604</NlmUniqueID><ISSNLinking>0254-6450</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x4e86;&#x89e3;&#x6211;&#x56fd;2008-2018&#x5e74;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x7684;&#x6d41;&#x884c;&#x75c5;&#x5b66;&#x7279;&#x5f81;&#xff0c;&#x4e3a;&#x91cd;&#x75c7;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x7684;&#x9632;&#x63a7;&#x63d0;&#x4f9b;&#x4f9d;&#x636e;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x4ece;&#x4e2d;&#x56fd;&#x75be;&#x75c5;&#x9884;&#x9632;&#x63a7;&#x5236;&#x4e2d;&#x5fc3;&#x4f20;&#x67d3;&#x75c5;&#x62a5;&#x544a;&#x4fe1;&#x606f;&#x7ba1;&#x7406;&#x7cfb;&#x7edf;&#x4e2d;&#x83b7;&#x53d6;2008-2018&#x5e74;&#x6240;&#x6709;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x4e2a;&#x6848;&#x8d44;&#x6599;&#xff0c;&#x91c7;&#x7528;&#x63cf;&#x8ff0;&#x6027;&#x6d41;&#x884c;&#x75c5;&#x5b66;&#x65b9;&#x6cd5;&#x5206;&#x6790;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x7684;&#x4e09;&#x95f4;&#x5206;&#x5e03;&#x3001;&#x75c5;&#x539f;&#x6784;&#x6210;&#x53ca;&#x53d8;&#x5316;&#xff0c;&#x91c7;&#x7528;Joinpoint&#x56de;&#x5f52;&#x6a21;&#x578b;&#x5206;&#x6790;&#x91cd;&#x75c7;&#x7387;&#x3001;&#x91cd;&#x75c7;&#x6bd4;&#x4f8b;&#x548c;&#x91cd;&#x75c7;&#x75c5;&#x6b7b;&#x7387;&#x7684;&#x53d8;&#x5316;&#x8d8b;&#x52bf;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> 2008-2018&#x5e74;&#x5168;&#x56fd;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;157 065&#x4f8b;&#xff0c;&#x5e74;&#x5747;&#x91cd;&#x75c7;&#x7387;&#x4e3a;1.05/10&#x4e07;&#xff0c;&#x91cd;&#x75c7;&#x6bd4;&#x4f8b;&#x4e3a;0.76<i>%</i>&#xff0c;&#x91cd;&#x75c7;&#x75c5;&#x6b7b;&#x7387;&#x4e3a;2.34<i>%</i>&#xff0c;&#x91cd;&#x75c7;&#x7387;&#x548c;&#x91cd;&#x75c7;&#x6bd4;&#x4f8b;2010&#x5e74;&#x540e;&#x51fa;&#x73b0;&#x4e0b;&#x964d;&#x8d8b;&#x52bf;&#xff0c;&#x91cd;&#x75c7;&#x75c5;&#x6b7b;&#x7387;2014&#x5e74;&#x540e;&#x663e;&#x8457;&#x4e0b;&#x964d;&#x3002;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x7537;&#x6027;&#x9ad8;&#x4e8e;&#x5973;&#x6027;&#xff08;1.78&#x2236;1&#xff09;&#xff0c;&#x4ee5;&#x2264;3&#x5c81;&#x5a74;&#x5e7c;&#x513f;&#x4e3a;&#x4e3b;&#xff08;91.47<i>%</i>&#xff09;&#xff0c;EV-A71&#x5f15;&#x8d77;&#x7684;&#x91cd;&#x75c7;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x4e2d;&#x4f4d;&#x5e74;&#x9f84;&#x6700;&#x9ad8;&#xff08;1.99&#x5c81;&#xff09;&#x4e14;&#x9010;&#x5e74;&#x5347;&#x9ad8;&#xff0c;&#x5176;&#x4ed6;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#x611f;&#x67d3;&#x5728;&#x2264;1&#x5c81;&#x5a74;&#x513f;&#x4e2d;&#x6784;&#x6210;&#x8f83;&#x9ad8;&#xff08;66.56<i>%</i>&#xff09;&#x3002;4-7&#x6708;&#x4e3a;&#x4e3b;&#x8981;&#x7684;&#x53d1;&#x75c5;&#x9ad8;&#x5cf0;&#xff0c;2018&#x5e74;&#x5176;&#x4ed6;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#x4ee3;&#x66ff;EV-A71&#x6210;&#x4e3a;&#x4f18;&#x52bf;&#x8840;&#x6e05;&#x578b;&#xff08;61.97<i>%</i>&#xff09;&#x3002;&#x897f;&#x5357;&#x90e8;&#x3001;&#x4e2d;&#x90e8;&#x53ca;&#x4e1c;&#x90e8;&#x5730;&#x533a;&#x90e8;&#x5206;&#x7701;&#x4efd;&#x4e3a;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x9ad8;&#x53d1;&#x7701;&#x4efd;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x6211;&#x56fd;&#x5927;&#x9646;&#x5730;&#x533a;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x91cd;&#x75c7;&#x7387;&#x3001;&#x91cd;&#x75c7;&#x6bd4;&#x4f8b;&#x53ca;&#x91cd;&#x75c7;&#x75c5;&#x6b7b;&#x7387;&#x6574;&#x4f53;&#x5448;&#x4e0b;&#x964d;&#x8d8b;&#x52bf;&#xff0c;&#x90e8;&#x5206;&#x7701;&#x4efd;&#x4f18;&#x52bf;&#x75c5;&#x539f;&#x7531;EV-A71&#x8f6c;&#x4e3a;&#x5176;&#x4ed6;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#xff0c;&#x5e94;&#x52a0;&#x5f3a;&#x91cd;&#x70b9;&#x4eba;&#x7fa4;&#x3001;&#x9ad8;&#x53d1;&#x5b63;&#x8282;&#x3001;&#x533a;&#x57df;&#x9632;&#x63a7;&#x5de5;&#x4f5c;&#xff0c;&#x5f00;&#x5c55;&#x591a;&#x79cd;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x75c5;&#x539f;&#x76d1;&#x6d4b;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiological characteristic</Keyword><Keyword MajorTopicYN="N">Hand, foot, and mouth disease</Keyword><Keyword MajorTopicYN="N">Severe case</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>10</Day><Hour>3</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33297642</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112338-20200201-00063</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>